CN103055165A - Medicament for treating cervical disease - Google Patents

Medicament for treating cervical disease Download PDF

Info

Publication number
CN103055165A
CN103055165A CN2012105831430A CN201210583143A CN103055165A CN 103055165 A CN103055165 A CN 103055165A CN 2012105831430 A CN2012105831430 A CN 2012105831430A CN 201210583143 A CN201210583143 A CN 201210583143A CN 103055165 A CN103055165 A CN 103055165A
Authority
CN
China
Prior art keywords
content
radix
poria
medicine
safflower
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012105831430A
Other languages
Chinese (zh)
Inventor
杨海霞
胡明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QINGDAO AIWEI INTERACTIVE INFORMATION TECHNOLOGY Co Ltd
Original Assignee
QINGDAO AIWEI INTERACTIVE INFORMATION TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QINGDAO AIWEI INTERACTIVE INFORMATION TECHNOLOGY Co Ltd filed Critical QINGDAO AIWEI INTERACTIVE INFORMATION TECHNOLOGY Co Ltd
Priority to CN2012105831430A priority Critical patent/CN103055165A/en
Publication of CN103055165A publication Critical patent/CN103055165A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a medicament for treating cervical diseases, and the medicament includes Sichuan lovage root, gastrodia rhizome, fleece-flower root, salvia root, abalone shell, poria, millettla, eucommia, safflower, etc., and the medicament contains about 10-20 % of Sichuan lovage root, about 5-15%gastrodia rhizome, about 10-20% of fleece-flower root, about 10-15% of salvia root, about 5-10% of abalone shell, about 5-10% of poria, about 5-10% of millettla, about 5-10% of eucommia, about 10-15% of safflower, and the balance being excipients.

Description

A kind of medicine for the treatment of cervical spondylosis
Technical field
The present invention relates to a kind of medicine for the treatment of cervical spondylosis.
Background technology
Along with people use computer more and more, the white collar clan of office is for a long time before computer, quantity of motion is fewer and feweri, and a lot of people have suffered from cervical spondylosis, and serious also can cause giddy, dizzy, but the most medicine that is used for the treatment of cervical spondylosis is Western medicine in the market, comprised a large amount of chemical compositions, side effect is large, cures the symptoms, not the disease, and Chinese herbal medicine is pure natural medicine, and the Chinese herbal medicine of developing thus the treatment cervical spondylosis seems particularly urgent.
Summary of the invention
The invention provides a kind of medicine for the treatment of cervical spondylosis, it comprises Rhizoma Chuanxiong, Rhizoma Gastrodiae, the Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Concha Haliotidis, Poria, Caulis Spatholobi, the Cortex Eucommiae, Flos Carthami etc., wherein Rhizoma Chuanxiong content is about 10-20%, Rhizoma Gastrodiae content and is about 10-20%, Radix Polygoni Multiflori content and is about 5-15%, Radix Salviae Miltiorrhizae content and is about 10-20%, Radix Angelicae Sinensis content and is about 10-15%, Concha Haliotidis content and is about 5-10%, Poria content and is about 5-10%, Caulis Spatholobi content and is about that 5-10%, Cortex Eucommiae content are about 5-10%, safflower content is about 10-15%, and all the other are adjuvant.
The specific embodiment
The invention provides a kind of medicine for the treatment of cervical spondylosis, it comprises Rhizoma Chuanxiong, Rhizoma Gastrodiae, the Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Concha Haliotidis, Poria, Caulis Spatholobi, the Cortex Eucommiae, Flos Carthami etc., wherein Rhizoma Chuanxiong content is about 10-20%, Rhizoma Gastrodiae content and is about 10-20%, Radix Polygoni Multiflori content and is about 5-15%, Radix Salviae Miltiorrhizae content and is about 10-20%, Radix Angelicae Sinensis content and is about 10-15%, Concha Haliotidis content and is about 5-10%, Poria content and is about 5-10%, Caulis Spatholobi content and is about that 5-10%, Cortex Eucommiae content are about 5-10%, safflower content is about 10-15%, and all the other are adjuvant.
Embodiment 1
The medicine of this treatment cervical spondylosis, wherein Rhizoma Chuanxiong content is about 20%, Rhizoma Gastrodiae content is about 10%, Radix Polygoni Multiflori content is about 15%, Radix Salviae Miltiorrhizae content is about 10%, Radix Angelicae Sinensis content is about 15%, Concha Haliotidis content is about 5%, Poria content is about 10%, Caulis Spatholobi content is about 5%, Cortex Eucommiae content is about 10%, safflower content is about 10%, and all the other are adjuvant.
Embodiment 2
The medicine of this treatment cervical spondylosis, wherein Rhizoma Chuanxiong content is about 10%, Rhizoma Gastrodiae content is about 20%, Radix Polygoni Multiflori content is about 5%, Radix Salviae Miltiorrhizae content is about 20%, Radix Angelicae Sinensis content is about 10%, Concha Haliotidis content is about 10%, Poria content is about 5%, Caulis Spatholobi content is about 10%, Cortex Eucommiae content is about 5%, safflower content is about 15%, and all the other are adjuvant.
Embodiment 3
The medicine of this treatment cervical spondylosis, wherein Rhizoma Chuanxiong content is about 15%, Rhizoma Gastrodiae content is about 15%, Radix Polygoni Multiflori content is about 10%, Radix Salviae Miltiorrhizae content is about 15%, Radix Angelicae Sinensis content is about 13%, Concha Haliotidis content is about 7%, Poria content is about 8%, Caulis Spatholobi content is about 7%, Cortex Eucommiae content is about 8%, safflower content is about 12%, and all the other are adjuvant.

Claims (3)

1. medicine for the treatment of cervical spondylosis, it comprises Rhizoma Chuanxiong, Rhizoma Gastrodiae, the Radix Polygoni Multiflori, Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Concha Haliotidis, Poria, Caulis Spatholobi, the Cortex Eucommiae, Flos Carthami.
2. medicine as claimed in claim 1, wherein Rhizoma Chuanxiong content is about 10-20%, Rhizoma Gastrodiae content and is about 10-20%, Radix Polygoni Multiflori content and is about 5-15%, Radix Salviae Miltiorrhizae content and is about 10-20%, Radix Angelicae Sinensis content and is about 10-15%, Concha Haliotidis content and is about 5-10%, Poria content and is about 5-10%, Caulis Spatholobi content and is about that 5-10%, Cortex Eucommiae content are about 5-10%, safflower content is about 10-15%, and all the other are adjuvant.
3. medicine as claimed in claim 2, wherein Rhizoma Chuanxiong content is about 15%, Rhizoma Gastrodiae content is about 15%, Radix Polygoni Multiflori content is about 10%, Radix Salviae Miltiorrhizae content is about 15%, Radix Angelicae Sinensis content is about 13%, Concha Haliotidis content is about 7%, Poria content is about 8%, Caulis Spatholobi content is about 7%, Cortex Eucommiae content is about 8%, safflower content is about 12%, and all the other are adjuvant.
CN2012105831430A 2012-12-28 2012-12-28 Medicament for treating cervical disease Pending CN103055165A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2012105831430A CN103055165A (en) 2012-12-28 2012-12-28 Medicament for treating cervical disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2012105831430A CN103055165A (en) 2012-12-28 2012-12-28 Medicament for treating cervical disease

Publications (1)

Publication Number Publication Date
CN103055165A true CN103055165A (en) 2013-04-24

Family

ID=48098260

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2012105831430A Pending CN103055165A (en) 2012-12-28 2012-12-28 Medicament for treating cervical disease

Country Status (1)

Country Link
CN (1) CN103055165A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1293998A (en) * 1999-10-21 2001-05-09 魏加忠 Chinese medicine for treating diseases of cervical or lumbar vertebra
CN1686510A (en) * 2005-04-14 2005-10-26 赵宏伟 Ready prepared Chinese medicine for preventing and treating brain apoplexia
CN1903328A (en) * 2006-07-31 2007-01-31 何新明 Health-care medicated wine for treating fracture and injury, cervical vertebrae ache and lumbar vertebrae ache
CN101301434A (en) * 2008-07-10 2008-11-12 刘长迎 Chinese medicinal composition for treating cervical vertebra disease
CN101317968A (en) * 2008-07-15 2008-12-10 王跃进 Cervical vertebra plaster medicine
CN102258699A (en) * 2011-08-23 2011-11-30 冯根源 Chinese patent medicament for treating cervical spondylosis and cranial nerve vascular diseases and preparation method thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1293998A (en) * 1999-10-21 2001-05-09 魏加忠 Chinese medicine for treating diseases of cervical or lumbar vertebra
CN1686510A (en) * 2005-04-14 2005-10-26 赵宏伟 Ready prepared Chinese medicine for preventing and treating brain apoplexia
CN1903328A (en) * 2006-07-31 2007-01-31 何新明 Health-care medicated wine for treating fracture and injury, cervical vertebrae ache and lumbar vertebrae ache
CN101301434A (en) * 2008-07-10 2008-11-12 刘长迎 Chinese medicinal composition for treating cervical vertebra disease
CN101317968A (en) * 2008-07-15 2008-12-10 王跃进 Cervical vertebra plaster medicine
CN102258699A (en) * 2011-08-23 2011-11-30 冯根源 Chinese patent medicament for treating cervical spondylosis and cranial nerve vascular diseases and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
夏基专: "自拟定眩饮治疗颈动脉型眩晕30例", 《实用中医内科杂志》 *
洪国灿: "椎动脉型颈椎病中药治疗的处方用药研究", 《国医论坛》 *
聂伟志: "椎动脉型颈椎病的中医药治疗研究进展", 《中国中医骨伤科杂志》 *

Similar Documents

Publication Publication Date Title
CN101129620A (en) Traditional Chinese medicine for treating nasosinusitis headache
CN103055165A (en) Medicament for treating cervical disease
CN103566322A (en) Medicine for treating chronic diarrhea
CN104491305A (en) Traditional Chinese medicine composition for treating anxiety neurasthenia
CN104740379A (en) Chinese medicinal composition for treating palpitation
CN104825701A (en) External application traditional Chinese medicine for treating scapulohumeral periarthritis
CN103212036A (en) Chinese medicament for treating cervical spondylosis
CN103566279A (en) Medicine for treating hypertension
CN105287893A (en) Kidney tonifying and blood circulation promoting decoction for treating osteoporosis
CN102309648A (en) Traditional Chinese medicine prescription for treating postpartum retention of lochia
CN101152330A (en) Traditional Chinese medicine for treating hysterical attack
CN103330763B (en) Chinese medicine for curing yin-deficiency chronic gastritis
CN104027615A (en) Traditional Chinese medicine composition for treating vertigo
CN103690717A (en) Traditional Chinese medicine preparation for treating stroke
CN104721450A (en) Traditional Chinese medicine for treating abnormal menstruation and preparation method thereof
CN104415301A (en) Traditional Chinese medicament for treating metrorrhagia and metrostaxis caused by menorrhagia
CN105641336A (en) Traditional Chinese medicine oral medicament for treating acne
CN105213706A (en) One is used for the treatment of osteoporotic two celestial kidney qi soup
CN104740048A (en) Treatment method for periarthritis of shoulder
CN104666463A (en) Method for treating insomnia by traditional Chinese medicine
CN102379944A (en) Orally-taking traditional Chinese medicine for treating insomnia
CN101757198A (en) Xiaofeng powder
CN105287869A (en) Meridian activating and marrow supplementing decoction for treating osteoporosis
CN102846890A (en) Chinese medicine prescription for treatment of hypomenorrhea
CN104547315A (en) Traditional Chinese medicine for treating dysmenorrheal

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130424